Category Archives: J Affect Disord

Dysfunctional attitudes or extreme response style as predictors of depressive relapse and recurrence after mobile cognitive therapy for recurrent depression.

Dysfunctional attitudes or extreme response style as predictors of depressive relapse and recurrence after mobile cognitive therapy for recurrent depression.
J Affect Disord. 2018 Sep 08;243:48-54
Authors: Brouwer … Continue reading

Posted in J Affect Disord | Tagged | Leave a comment

Development and external validation of a prediction rule for an unfavorable course of late-life depression: A multicenter cohort study.

Development and external validation of a prediction rule for an unfavorable course of late-life depression: A multicenter cohort study.

J Affect Disord. 2018 Apr 06;235:105-113

Authors: Maarsingh OR, Heymans MW, Verhaak PF, Penninx BWJH, Comijs HC

Abstract
BACKGROUND: Given the poor prognosis of late-life depression, it is crucial to identify those at risk. Our objective was to construct and validate a prediction rule for an unfavourable course of late-life depression.
METHODS: For development and internal validation of the model, we used The Netherlands Study of Depression in Older Persons (NESDO) data. We included participants with a major depressive disorder (MDD) at baseline (n = 270; 60-90 years), assessed with the Composite International Diagnostic Interview (CIDI). For external validation of the model, we used The Netherlands Study of Depression and Anxiety (NESDA) data (n = 197; 50-66 years). The outcome was MDD after 2 years of follow-up, assessed with the CIDI. Candidate predictors concerned sociodemographics, psychopathology, physical symptoms, medication, psychological determinants, and healthcare setting. Model performance was assessed by calculating calibration and discrimination.
RESULTS: 111 subjects (41.1%) had MDD after 2 years of follow-up. Independent predictors of MDD after 2 years were (older) age, (early) onset of depression, severity of depression, anxiety symptoms, comorbid anxiety disorder, fatigue, and loneliness. The final model showed good calibration and reasonable discrimination (AUC of 0.75; 0.70 after external validation). The strongest individual predictor was severity of depression (AUC of 0.69; 0.68 after external validation).
LIMITATIONS: The model was developed and validated in The Netherlands, which could affect the cross-country generalizability.
CONCLUSIONS: Based on rather simple clinical indicators, it is possible to predict the 2-year course of MDD. The prediction rule can be used for monitoring MDD patients and identifying those at risk of an unfavourable outcome.

PMID: 29655070 [PubMed – as supplied by publisher]

Continue reading

Posted in J Affect Disord | Tagged , | Leave a comment

Anxiety disorders and figural fluency: A measure of executive function.

Related Articles
Anxiety disorders and figural fluency: A measure of executive function.
J Affect Disord. 2018 Feb 17;234:38-44
Authors: Gulpers B, Lugtenburg A, Zuidersma M, Verhey FRJ, Voshaar RCO
Abstract
Continue reading

Posted in J Affect Disord | Tagged , | Leave a comment

The effects of low-intensity narrow-band blue-light treatment compared to bright white-light treatment in seasonal affective disorder.

The effects of low-intensity narrow-band blue-light treatment compared to bright white-light treatment in seasonal affective disorder.

J Affect Disord. 2018 Feb 21;232:48-51

Authors: Meesters Y, Duijzer WB, Hommes V

Abstract
BACKGROUND: Ever since a new photoreceptor was discovered with a highest sensitivity to 470-490 nm blue light, it has been speculated that blue light has some advantages in the treatment of Seasonal Affective Disorder (SAD) over more traditional treatments. In this study we compared the effects of exposure to narrow-band blue light (BLUE) to those of broad-wavelength white light (BLT) in the treatment of SAD.
METHODS: In a 15-day design, 45 patients suffering from SAD completed 30-min sessions of light treatment on 5 consecutive days. 21 subjects received white-light treatment (BLT, broad-wavelength without UV, 10 000 lx, irradiance 31.7 W/m2), 24 subjects received narrow-band blue light (BLUE, 100 lx, irradiance 1.0 W/m2). All participants completed weekly questionnaires concerning mood and energy levels, and were also assessed by means of the SIGH-SAD, which is the primary outcome measure.
RESULTS: On day 15, SIGH-SAD ratings were significantly lower than on day 1 (BLT 73.2%, effect size 3.37; BLUE 67%, effect size 2.63), which outcomes were not statistically significant different between both conditions.
LIMITATIONS: Small sample size.
CONCLUSIONS: Light treatment is an effective treatment for SAD. The use of narrow-band blue light is equally effective as a treatment using bright white-light.

PMID: 29477098 [PubMed – as supplied by publisher]

Continue reading

Posted in J Affect Disord | Tagged , | Leave a comment

Uric acid in major depressive and anxiety disorders.

Related Articles

Uric acid in major depressive and anxiety disorders.

J Affect Disord. 2017 Sep 06;225:684-690

Authors: Black CN, Bot M, Scheffer PG, Snieder H, Penninx BWJH

Abstract
BACKGROUND: Uric acid has neuroprotective effects, owing to its antioxidant properties. Lowered antioxidant capacity, causing increased oxidative stress, may be involved in affective disorders and might be altered by antidepressants. This study investigated the association of plasma uric acid, the greatest contributor to blood antioxidant capacity, with major depressive disorder (MDD) and anxiety disorders.
METHODS: Data were from the Netherlands Study of Depression and Anxiety including patients with current (N = 1648), remitted (N = 609) MDD and/or anxiety disorders (of which N = 710 antidepressant users) and 618 controls. Diagnoses were established with the Composite International Diagnostic Interview. Symptom severity was assessed with the Inventory of Depressive Symptoms-Self Report, Beck Anxiety Inventory and Fear Questionnaire. Uric acid was measured in plasma. Analyses were adjusted for sociodemographic, health and lifestyle variables.
RESULTS: Plasma uric acid adjusted mean levels were lower in current MDD and/or anxiety disorder(s) (289μmol/l) compared to remitted disorders (298μmol/l, p < .001) and controls (299μmol/l, p < .001; Cohen’s d .10). This finding was independent of antidepressant use. Depressive (β-.05, p = .0012), anxiety (β-.04, p = .009) and phobic (β-.03, p = .036) symptom severity, and symptom duration (β-.04, p = .009) were negatively associated with uric acid.
LIMITATIONS: Limitations include the lack of data on dietary intake which could be a potential confounding factor. From these cross-sectional findings, the association between uric acid and psychopathology cannot be inferred to be causal.
CONCLUSION: This large scale study finds plasma uric acid levels are lower in current, but not remitted, MDD and/or anxiety disorders, according to a dose-response gradient. This suggests the involvement of decreased antioxidant status in affective disorders, and points to their potential as an avenue for treatment.

PMID: 28917195 [PubMed – as supplied by publisher]

Continue reading

Posted in J Affect Disord | Tagged , | Leave a comment

Positive affective functioning in anhedonic individuals’ daily life: Anything but flat and blunted.

Related Articles
Positive affective functioning in anhedonic individuals’ daily life: Anything but flat and blunted.
J Affect Disord. 2017 Apr 21;218:437-445
Authors: Heininga VE, Van Roekel E, Ahles JJ, Oldehinkel AJ… Continue reading

Posted in J Affect Disord | Tagged , | Leave a comment

The ten-year course of depression in primary care and long-term effects of psychoeducation, psychiatric consultation and cognitive behavioral therapy.

Related Articles
The ten-year course of depression in primary care and long-term effects of psychoeducation, psychiatric consultation and cognitive behavioral therapy.
J Affect Disord. 2017 Mar 30;217:174-182
Authors: … Continue reading

Posted in J Affect Disord | Tagged , | Leave a comment

The relation between chronotype and treatment outcome with light therapy on a fixed time schedule.

Related Articles

The relation between chronotype and treatment outcome with light therapy on a fixed time schedule.

J Affect Disord. 2016 May 24;202:87-90

Authors: Knapen SE, Gordijn MC, Meesters Y

Abstract
BACKGROUND: Seasonal affective disorder (SAD) is characterized by recurrent episodes of major depression in a seasonal pattern. The therapy of choice is light therapy (LT). It is suggested that LT should be administered relative to the chronotype of the patient, with the optimal timing earlier for morning than for evening types. This study aims to retrospectively investigate the relation between chronotype and the effect of LT on a fixed time in the morning in a population of SAD patients.
METHODS: Data from four different studies conducted at the University Center of Psychiatry in Groningen, the Netherlands was used. Data from 132 patients was used (103 women). Depression score was determined by a structured interview (SIGH-SAD) prior to LT and after LT. Prior to LT morningness/eveningness preference of the patient was determined by the ‘Morningness/Eveningness Questionnaire’ (MEQ). All patients received LT at 8:00 AM at the clinic, independent of chronotype.
RESULTS: Patients had an average MEQ score of 51.5±8.2. There was no significant relationship between MEQ score and therapy success as measured with the SIGH-SAD (F2,129=0.05, ns). When patients were divided by chronotype (ranging from definite morning to moderate evening) no significant relation between MEQ score and therapy success was found (F2,129=0.02, ns).
LIMITATIONS: Retrospective design.
CONCLUSIONS: The lack of a significant relationship between chronotype, as measured with the MEQ, and therapy success with LT at a fixed timepoint may indicate that the anti-depressive effect of morning light in SAD patients is not explained by a phase shift of the biological clock.

PMID: 27259079 [PubMed – as supplied by publisher]

Continue reading

Posted in J Affect Disord | Tagged | Leave a comment

The identification of symptom-based subtypes of depression: A nationally representative cohort study.

Related Articles

The identification of symptom-based subtypes of depression: A nationally representative cohort study.

J Affect Disord. 2015 Oct 25;190:395-406

Continue reading

Posted in J Affect Disord | Tagged | Leave a comment

Low stability of diagnostic classifications of anxiety disorders over time: A six-year follow-up of the NESDA study.

Low stability of diagnostic classifications of anxiety disorders over time: A six-year follow-up of the NESDA study.

J Affect Disord. 2015 Oct 28;190:310-315

Authors: …

Continue reading

Posted in J Affect Disord | Tagged | Leave a comment

Daily symptom ratings for studying premenstrual dysphoric disorder: A review.

Daily symptom ratings for studying premenstrual dysphoric disorder: A review.
J Affect Disord. 2015 Sep 14;189:43-53
Authors: Bosman RC, Jung SE, Miloserdov K, Schoevers RA, Aan Het Rot M
Abstract
BAC… Continue reading

Posted in J Affect Disord | Tagged , | Leave a comment

Predicting long-term depression outcome using a three-mode principal component model for depression heterogeneity.

Predicting long-term depression outcome using a three-mode principal component model for depression heterogeneity.
J Affect Disord. 2015 Sep 12;189:1-9
Authors: Monden R, Stegeman A, Conradi HJ, de Jonge P, Wardenaar… Continue reading

Posted in J Affect Disord | Leave a comment

The association between cardiac rehabilitation and mortality risk for myocardial infarction patients with and without depressive symptoms.

The association between cardiac rehabilitation and mortality risk for myocardial infarction patients with and without depressive symptoms.

J Affect Disord. 2015 Sep 2;188:278-283

Authors: Meurs M, Burger H, van Riezen J, Slaets JP, Rosmalen JG, van Melle JP, Roest AM, de Jonge P

Abstract
BACKGROUND: Post-myocardial infarction (MI) depression is associated with reduced adherence to cardiac rehabilitation (CR) and increased mortality risk. The present study investigated whether all-cause mortality reduction associated with CR is different for MI-patients with and without depressive symptoms.
METHODS: Data of 2198 post-MI patients from the Depression after Myocardial Infarction (DepreMI) study and Myocardial Infarction and Depression Intervention Trial (MIND-IT) was used. Depression was assessed at hospitalization, defined as a score≥10 on the Beck Depression Inventory (BDI). Participation in CR was assessed with a self-report questionnaire, 12 months post-MI. Cox regression was used to estimate hazard ratios (HR) for all-cause mortality, up till 10 years post-MI. Missing data was imputed, using multiple imputation.
RESULTS: 878 (52%) Patients attended CR, 517 (26%) patients had a BDI score ≥10, and 379 (18%) patients died during the follow-up period. Overall, CR was not associated with a lower mortality risk (HR: 0.83; 0.54-1.30; p=0.41), adjusted for age, sex, left ventricle ejection fraction, previous MI, and past or current heart failure. However, there was a significant interaction between depression and CR on mortality (HR: 0.49; 0.27-0.90; p=0.02). CR was significantly associated with reduced mortality in depressed patients (HR: 0.48; 0.28-0.84; p=0.01), but not in non-depressed patients (HR: 1.09; 0.63-1.89; p=0.74).
LIMITATIONS: Patients were not randomized to CR. We had no information about the specific reasons of clinicians to offer CR and about the patients’ motives to participate.
CONCLUSIONS: CR was associated with reduced mortality risk only for MI-patients with depression. Clinicians should therefore particularly encourage MI-patients with depression to participate in CR.

PMID: 26384014 [PubMed – as supplied by publisher]

Continue reading

Posted in J Affect Disord | Tagged , | Leave a comment

Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial.

Related Articles

Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled…

Continue reading

Posted in J Affect Disord | Tagged | Leave a comment

Personality and cognitive vulnerability in remitted recurrently depressed patients.

Related Articles

Personality and cognitive vulnerability in remitted recurrently depressed patients.

J Affect Disord. 2015 Mar 1;173:97-104

Authors: van Rijsbergen GD, Kok GD, Elgersma HJ, Hollon SD, Bockting CL

Abstract
INTRODUCTION: Personality disorders (PDs) have been associated with a poor prognosis of Major Depressive Disorder (MDD). The aim of the current study was to examine cognitive vulnerability (i.e., dysfunctional beliefs, extremity of beliefs, cognitive reactivity, and rumination) that might contribute to this poor prognosis of patients with PD comorbidity.
METHODS: 309 outpatients with remitted recurrent MDD (SCID-I; HAM-D17 ≤ 10) were included within two comparable RCTs and were assessed at baseline with the Personality Diagnostic Questionnaire-4(+) (PDQ-4(+)), the Dysfunctional Attitude Scale Version-A (DAS-A), the Leiden Index of Depression Sensitivity (LEIDS), the Ruminative Response Scale (RRS), and the Inventory of Depressive Symptomatology-Self Report (IDS-SR).
RESULTS: We found an indication that the PD prevalence was 49.5% in this remitted recurrently depressed sample. Having a PD (and higher levels of personality pathology) was associated with dysfunctional beliefs, cognitive reactivity, and rumination. Extreme ‘black and white thinking’ on the DAS was not associated with personality pathology. Brooding was only associated with a Cluster C classification (t(308) = 4.03, p < .001) and with avoidant PD specifically (t(308) = 4.82, p < .001), while surprisingly not with obsessive-compulsive PD.
LIMITATIONS: PDs were assessed by questionnaire and the analyses were cross-sectional in nature.
CONCLUSION: Being the first study to examine cognitive reactivity and rumination in patients with PD and remitted MDD, we demonstrated that even after controlling for depressive symptomatology, dysfunctional beliefs, cognitive reactivity, and rumination were associated with personality pathology. Rumination might be a pathway to relapse for patients with avoidant PD. Replication of our findings concerning cognitive vulnerability and specific PDs is necessary.

PMID: 25462402 [PubMed – indexed for MEDLINE]

Continue reading

Posted in J Affect Disord | Leave a comment

Training mental health professionals in suicide practice guideline adherence: Cost-effectiveness analysis alongside a randomized controlled trial.

Related Articles

Training mental health professionals in suicide practice guideline adherence: Cost-effectiveness analysis alongside a randomized controlled trial.

J Affect Disord. 2015 Jul 26;186:203-210

Authors: de Beurs DP, Bosmans JE, de Groot MH, de Keijser J, van Duijn E, de Winter RF, Kerkhof AJ

Abstract
BACKGROUND: There is a lack of information on the cost-effectiveness of suicide prevention interventions. The current study examines the cost-effectiveness of a multifaceted structured intervention aiming to improve adherence to the national suicide practice guideline in comparison with usual implementation.
METHODS: In the intervention condition, professionals of psychiatric departments were trained using an e-learning supported Train-the-Trainer program. Newly admitted suicidal patients were assessed as soon as their department was trained and at 3 months follow-up. The primary outcome was improvement in suicide ideation. Missing cost and effect data were imputed using multiple imputation. Cost-effectiveness planes were plotted, and cost-effectiveness acceptability curves were estimated.
RESULTS: For the total group of suicidal patients (n=566), no effect of the intervention on suicide ideation or costs was found. For a subgroup of depressed suicidal patients (n=154, intervention=75, control=79), mean level of suicide ideation decreased with 2.7 extra points in the intervention condition, but this was not statistically significant. For this subgroup, the intervention may be considered cost-effective in comparison with usual implementation if society is willing to pay≥€ 6100 per unit of effect on the suicide ideation scale extra.
LIMITATIONS: Considering the cost outcomes, we had almost no cases that were complete, and heavily relied on statistical techniques to impute the missing data. Also, diagnoses were not derived from structured clinical interviews.
CONCLUSIONS: We presented the first randomized trial (trial registration: The Netherlands Trial Register (NTR3092 www.trialregister.nl)) on cost-effectiveness of a suicide practice guideline implementation in mental health care. The intervention might be considered cost-effective for depressed suicidal patients if society is willing to make substantial investments.

PMID: 26247913 [PubMed – as supplied by publisher]

Continue reading

Posted in J Affect Disord | Leave a comment

Enduring effects of Preventive Cognitive Therapy in adults remitted from recurrent depression: A 10 year follow-up of a randomized controlled trial.

Related Articles
Enduring effects of Preventive Cognitive Therapy in adults remitted from recurrent depression: A 10 year follow-up of a randomized controlled trial.
J Affect Disord. 2015 Jul 11;185:188-194
Authors: B… Continue reading

Posted in J Affect Disord | Tagged , | Leave a comment

Loneliness is associated with poor prognosis in late-life depression: Longitudinal analysis of the Netherlands study of depression in older persons.

Loneliness is associated with poor prognosis in late-life depression: Longitudinal analysis of the Netherlands study of depression in older persons.
J Affect Disord. 2015 Jun 25;185:1-7
Authors: Holvast F, Burger H, … Continue reading

Posted in J Affect Disord | Leave a comment

Cognitive reactivity, self-depressed associations, and the recurrence of depression.

Cognitive reactivity, self-depressed associations, and the recurrence of depression.
J Affect Disord. 2015 May 18;183:300-309
Authors: Elgersma HJ, de Jong PJ, van Rijsbergen GD, Kok GD, Burger H, van der Does W, Pen… Continue reading

Posted in J Affect Disord | Leave a comment

Methylation of NR3C1 and SLC6A4 and internalizing problems. The TRAILS study.

Methylation of NR3C1 and SLC6A4 and internalizing problems. The TRAILS study.

J Affect Disord. 2015 Apr 6;180:97-103

Authors: van der Knaap LJ, van Oort FV, Verhulst FC, Oldehinkel AJ, Riese H

Abstract
BACKGROUND: The relationship between early adverse life events and later internalizing problems could be mediated by DNA methylation. Adversity has been associated with higher methylation levels in the glucocorticoid receptor gene (NR3C1) and the serotonin transporter gene (SLC6A4) in adolescents. We investigated cross-sectional and prospective associations of NR3C1 and SLC6A4 methylation with adolescents׳ clinical diagnoses of internalizing disorders and internalizing symptom scores.
METHODS: In a population sample (mean age=16.2) we measured DNA methylation in three regions of NR3C1 (NR3C1_1, N=454; NR3C1_2, N=904; NR3C1_3, N=412) and one region of SLC6A4 (N=939) at baseline. Internalizing problems were operationalized as clinical DSM-IV diagnoses, assessed at 3 year follow-up with a diagnostic interview, and internalizing symptom scores, assessed with Self-Report questionnaires at baseline and follow-up.
RESULTS: Only NR3C1_1 methylation was positively associated with risk of lifetime internalizing disorders, and with symptom scores at follow-up. However, after accounting for baseline symptom scores there was only a tendency for association with internalizing symptom scores at follow-up. There was no association between SLC6A4 methylation and risk of lifetime internalizing disorders. SLC6A4 methylation and internalizing symptom scores showed a tendency for association, also after accounting for baseline symptom scores.
LIMITATIONS: There was no repeated measure of DNA methylation to study causality between methylation and internalizing problems. Gene expression data were not available.
CONCLUSIONS: Although the role of gene methylation in the development of internalizing problems remains unclear, our findings suggest that gene methylation, particularly of NR3C1, may be involved in the development of internalizing problems in adolescence.

PMID: 25889020 [PubMed – as supplied by publisher]

Continue reading

Posted in J Affect Disord | Leave a comment